Low-Energy Aesthetic Device Trials Should Gather Quantitative Data – Panel
This article was originally published in The Gray Sheet
Executive SummaryPre-market trials for devices that use low levels of energy for cosmetic treatments such as body contouring and skin tightening should include clinical endpoints beyond patient satisfaction, an FDA advisory panel recommended last week
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.